Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SID 3712502
i
Other names:
SID 3712502, IMTPPE
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
University of Pittsburgh
Drug class:
Androgen receptor inhibitor
Related drugs:
‹
enzalutamide (78)
darolutamide (14)
bicalutamide (13)
flutamide (4)
EPI-7170 (1)
ONCT-534 (1)
rezvilutamide (0)
MVI-118 (0)
enzalutamide tablet (0)
enzalutamide (78)
darolutamide (14)
bicalutamide (13)
flutamide (4)
EPI-7170 (1)
ONCT-534 (1)
rezvilutamide (0)
MVI-118 (0)
enzalutamide tablet (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
AR expression
Prostate Cancer
AR expression
Prostate Cancer
SID 3712502
Sensitive: D – Preclinical
SID 3712502
Sensitive
:
D
SID 3712502
Sensitive: D – Preclinical
SID 3712502
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login